1. Home
  2. FULC vs BCAL Comparison

FULC vs BCAL Comparison

Compare FULC & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • BCAL
  • Stock Information
  • Founded
  • FULC 2015
  • BCAL 2001
  • Country
  • FULC United States
  • BCAL United States
  • Employees
  • FULC N/A
  • BCAL N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • BCAL Major Banks
  • Sector
  • FULC Health Care
  • BCAL Finance
  • Exchange
  • FULC Nasdaq
  • BCAL Nasdaq
  • Market Cap
  • FULC 468.1M
  • BCAL 528.7M
  • IPO Year
  • FULC 2019
  • BCAL N/A
  • Fundamental
  • Price
  • FULC $11.74
  • BCAL $18.37
  • Analyst Decision
  • FULC Buy
  • BCAL Buy
  • Analyst Count
  • FULC 7
  • BCAL 3
  • Target Price
  • FULC $10.43
  • BCAL $20.00
  • AVG Volume (30 Days)
  • FULC 922.1K
  • BCAL 178.3K
  • Earning Date
  • FULC 10-29-2025
  • BCAL 10-28-2025
  • Dividend Yield
  • FULC N/A
  • BCAL N/A
  • EPS Growth
  • FULC N/A
  • BCAL N/A
  • EPS
  • FULC N/A
  • BCAL 1.92
  • Revenue
  • FULC N/A
  • BCAL $187,714,000.00
  • Revenue This Year
  • FULC N/A
  • BCAL $72.44
  • Revenue Next Year
  • FULC N/A
  • BCAL $2.79
  • P/E Ratio
  • FULC N/A
  • BCAL $9.56
  • Revenue Growth
  • FULC 2752.05
  • BCAL 139.72
  • 52 Week Low
  • FULC $2.32
  • BCAL $11.87
  • 52 Week High
  • FULC $12.14
  • BCAL $19.39
  • Technical
  • Relative Strength Index (RSI)
  • FULC 72.74
  • BCAL 56.10
  • Support Level
  • FULC $7.51
  • BCAL $18.26
  • Resistance Level
  • FULC $9.05
  • BCAL $19.15
  • Average True Range (ATR)
  • FULC 0.80
  • BCAL 0.50
  • MACD
  • FULC 0.27
  • BCAL -0.09
  • Stochastic Oscillator
  • FULC 89.63
  • BCAL 25.19

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

Share on Social Networks: